| Azelaic Acid | Leo Pharma | ||
| 15%; Gel, Topical |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
|
Less Than 5
|
Less Than 5
|
||
| Indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. | |||
|
Yes
| |||
| Finacea | Patent 1 |
|---|---|
| ******** | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| ******** | *** \ ** | *** **, **** | **** ** ** | ******** | ******** ** *** **, **** |
| Azelaic Acid | Leo Pharma | ||
| 15%; Aerosol, Foam, Topical |
Less Than $1000 mn
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
Less Than 5
|
||
|
Less Than 5
|
None | ||
| Indicated for topical treatment of the inflammatory papules and pustules of mild to moderate rosacea | |||
|
Yes
| |||
| Finacea | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 |
|---|---|---|---|---|---|---|---|---|---|
| **** | ******* | **** *** | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| *** (****) | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
| Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
|---|---|---|---|---|---|
| **** | *** \ *** | **** *, **** | ******* | ******** ************ | ******* *** **** *** *** **** |
| ******* | ** \ ** | *** **, **** | ******* | ********* ******** | ***** *** **** *********** |
| *** (****) | ** \ ** | *** *, **** | ******* | ********* ******** | ***** *** **** *********** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|